Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism5-HT4 receptor agonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanismβ-adrenoceptors agonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Eurapharm Inc.
0 Patents (Medical) associated with Eurapharm Inc.
100 Deals associated with Eurapharm Inc.
100 Translational Medicine associated with Eurapharm Inc.